Statistics
Publications
2
Citations
60
H-Index
2
Active since
2022
Affiliations
Hongchang Li is an author at Beijing Proteome Research Center specializing in lung cancer pharmacotherapy, neuroscience, and proteasome inhibitor therapy.
Publications per year
2022–2023
2
2
Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer
Y Zhang, Tongde Du, Na Liu et al. · Cell Death and Disease · 2023 · 20 citations · Full text
Medicine, Oncology, Pharmacology +12
1–2 of 2